Texas Rangers updates center on Jon Gray’s Thoracic Outlet Syndrome symptoms, with doctors leaning toward the neurologic variant. If confirmed, Botox-based nerve treatments could shorten his IL stay, potentially allowing a return near the minimum 15 days; vascular TOS would require rib removal and likely end the season. The club stresses diagnostics are ongoing and prognosis remains uncertain, but optimism persists for a swift, minor setback recovery.

Meanwhile, Tyler Mahle has been on the IL since June 12 with right shoulder fatigue and is ramping up by throwing fastballs off a mound, with live BP likely coming soon. The team may slot Mahle back in as a reliever or short-stint starter rather than a long-term rotation piece, potentially delaying a full return by about two weeks. Chris Martin and Jacob Webb continue rehab progress (calf and back spasms, respectively) with limited timelines and potential September roles in a contention push.

Overall, the Rangers’ bullpen and rotation depth will be closely watched as diagnostics unfold, with the season potentially shaping decisions for next year depending on returns and health trajectories. The emphasis is on keeping Gray, Mahle, Martin, and Webb healthy while preserving solid options for September and beyond.